Our results help in better understanding the role of GDCA/S1PR2/ZBP1/p-MLKL mediated macrophage necroptosis in cholestatic liver diseases, and might provide novel therapeutic strategies to attenuate BA liver fibrosis. This evidence concerns the gene GNAT3 and Hepatic fibrosis.